TATFAR Reports and Publications

Progress Reports

2021 progress report
TATFAR 2021 Progress Report
TATFAR 2021 Progress Report summarizing work from 2016-2020 to address the growing global threat of...
Download
Download
Front cover of TATFAR 2014 Progress Report
TATFAR 2014 Progress Report
TATFAR 2014 Progress Report with recommendations for future collaboration between the US and EU.
Download
Download
210911 TATFAR Report
TATFAR 2011 Progress Report
Through regular meetings and several public consultations, the members of the TATFAR have identified...
Download
Download

Publications

Transatlantic Taskforces on Antimicrobial Resistance (TATFAR) In-person meeting, 14-15 November 2023, Luxembourg. Meeting Summary.
TATFAR In-person Meeting Summary
November 2023 TATFAR In-person meeting in Luxembourg. The meeting included competent authorities and...
Download
Download
TATFAR reporting of sales and use of antimicrobial
TATFAR Reporting of sales and use of antimicrobials per animal species
The aim of this paper is to present the different approaches taken by TATFAR member countries, highl...
Download
Download
2019 Targets for the reduction of antibiotic use in humans
2017 Pull incentives for antibacterial drug development
2016 Economic incentives for antimicrobial therapy development
TATFAR report cover for Report on the modified Delphi process for common structure
Report on the modified Delphi process for common structure and process indicators for hospital antimicrobial stewardship programs
Report on the modified Delphi process for common structure and process indicators for hospital antim...
Download
Download
Using Available Data Sources Track Antibiotic Use
Using Available Data Sources Track Antibiotic Use
Using available data sources at the country level to track antibiotic use.
Download
Download

Video clips

2018 TATFAR March 7-8 Meeting Opening Session

Historical Documents

EU-US Workshop report
EU-US Workshop Report
Report on the Joint EU-US Workshop
Download
Download
Nov 3 2009 summit declaration
TATFAR 2009 EU-US Summit Declaration
TATFAR 2009 EU-US Summit Declaration
Download
Download

Key Publications

Canada

Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action

European Union

A European One Health Action Plan against Antimicrobial Resistance (AMR)

Norway

Norway: Norwegian National Strategy Against Antibiotic Resistance 2015-2020

United States

Physician speaking with community member about their health.
About Antimicrobial Resistance Investments & Action
CDC’s Antimicrobial Resistance Solutions Initiative invests in national infrastructure to detect, re...
Fiscal Year 2021: U.S. National Action Plan Progress Report (published in 2023)
Download
Download
Year 5: U.S. National Action Plan Progress Report (published in 2022)
Year 4: U.S. National Action Plan Progress Report (published in 2020)
Year 3: U.S. National Action Plan Progress Report (published 2018)
Year 1 and 2: U.S. National Action Plan Progress Report (published 2017)

COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022, is a publication of the Antimicrobial Resistance Coordination and Strategy Unit within the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
COVID-19 & Antimicrobial Resistance
The U.S. lost progress combating AR in 2020 due, in large part, to effects of the COVID-19 pandemic.
2019 AR Threats Report
2019 Antibiotic Resistance Threats Report
CDC's 2019 AR Threats Report includes national estimates for 18 antimicrobial-resistant germs.
Antibiotic Use in the United States, 2023 Update: Progress and Opportunities
The report provides an overview of the current state of antibiotic use in human healthcare settings.

Initiatives for Addressing Antimicrobial Resistance in the Environment are two corresponding reports published in 2018 an overview of the current evidence base and ongoing knowledge gaps around antibiotic resistance in the environment (e.g. water, soil) and the potential effect on human health.

Executive summary (2018)
Download
Download
Current Situation and Challenges (2018)
Download
Download

Research, Innovation, and Policy: An Alliance Combating AMR, 2019
A European One Heath Action Plan against Antimicrobial Resistance, 2017
Progress report on the Action plan against the rising threats from Antimicrobial Resistance, 2015
Action plan against rising threats from Antimicrobial Resistance, 2011

INNUENDO: A cross‐sectoral platform for the integration of genomics in the surveillance of food‐borne pathogens (2018)
Final report of ENGAGE ‐ Establishing Next Generation sequencing Ability for Genomic analysis in Europe (2018)
Outcome of EC/EFSA questionnaire (2016) on use of Whole Genome Sequencing (WGS) for food‐ and waterborne pathogens isolated from animals, food, feed and related environmental samples in EU/EFTA countries (2018)
Comparative genomics of quinolone‐resistant and susceptible Campylobacter jejuni of poultry origin from major poultry producing European countries (GENCAMP) (2018)
ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food‐producing animals (2017)
Risk for the development of Antimicrobial Resistance (AMR) due to feeding of calves with milk containing residues of antibiotics (2017)
EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA) (2016)
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014
EU Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2013
ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals (2015)

Antimicrobial Resistance Funding

Find funding opportunities related to AMR on the agency or organization website or reach out to a contact listed for more information.

Antimicrobial Resistance Funding
Organization Contact Funding Opportunities
Biomedical Advanced Research and Development Authority (BARDA) Mark Albrecht, Mark.Albrecht@hhs.gov
Canadian Institutes of Health Research Edith Brochu, edith.brochu@cihr-irsc.gc.ca
CARB-X
CDC Rachael Aubert, vrl7@cdc.gov
Directorate-General for Research and Innovation Arjon van Hengel, Adrianus.Van-Hengel@ec.europa.eu
Innovative Medicines Initiative
Joint Programming Initiative on AMR Edith Brochu, edith.brochu@cihr-irsc.gc.ca
National Institute of Health Dennis Dixon dmdixon@niaid.nih.gov
Norwegian Institute of Public Health Christine Årdal, christine.ardal@fhi.no
U.S. Department of Agriculture Kathe Bjork, kathe.e.bjork@usda.gov
Print
Content Source:
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)